Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


11.02.2019

3 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Antivir Ther
1 BMC Pediatr
3 Clin Infect Dis
4 HIV Med
4 J Acquir Immune Defic Syndr
5 J Infect Dis
3 J Virol
1 JAMA
2 Lancet
1 Lancet Haematol
5 Lancet HIV
2 Lancet Infect Dis
1 Lancet Psychiatry
1 Lancet Public Health
1 N Engl J Med
2 Pediatr Infect Dis J
1 PLoS Comput Biol
1 PLoS Med
16 PLoS One
1 PLoS Pathog
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS Res Hum Retroviruses

  1. NETO PLF, Fernandes EMF, Nascimento MRO, Paes RP, et al
    Syphilis among newly diagnosed therapy-naive HIV patients in Belem, Para, Amazon Region of Brazil.
    AIDS Res Hum Retroviruses. 2019 Feb 1. doi: 10.1089/AID.2019.0007.
    PubMed     Text format     Abstract available

  2. RUISENOR-ESCUDERO H, Lyons C, Ketende S, Pitche V, et al
    Consistent Condom Use Among Men Who Have Sex With Men in Lome and Kara, Togo.
    AIDS Res Hum Retroviruses. 2019 Feb 3. doi: 10.1089/AID.2018.0212.
    PubMed     Text format     Abstract available

  3. HARRINGTON KRV, Rhyner P, Kempker RR
    Hospital Onset Varicella Central Nervous System Vasculitis in a Patient with HIV Infection.
    AIDS Res Hum Retroviruses. 2019 Feb 4. doi: 10.1089/aid.2018.0262.
    PubMed     Text format    


    Antimicrob Agents Chemother

  4. GYGLI SM, Keller PM, Ballif M, Blochliger N, et al
    Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02175.
    PubMed     Text format     Abstract available


    Antivir Ther

  5. MURTAGH R, Else LJ, Kuan KB, Khoo SH, et al
    Therapeutic drug monitoring of darunavir/ritonavir in pregnancy.
    Antivir Ther. 2019 Feb 7. doi: 10.3851/IMP3291.
    PubMed     Text format     Abstract available


    BMC Pediatr

  6. CISSE AM, Laborde-Balen G, Kebe-Fall K, Drame A, et al
    High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal.
    BMC Pediatr. 2019;19:47.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  7. VASQUEZ JJ, Hunt PW
    Participating in HIV Cure Research at the End of Life.
    Clin Infect Dis. 2019 Jan 31. pii: 5304836. doi: 10.1093.
    PubMed     Text format    

  8. CHAUDHURY CS, Mee T, Chairez C, McLaughlin M, et al
    Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance.
    Clin Infect Dis. 2019 Feb 2. pii: 5305922. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. SANDSTROM TS, Burke Schinkel SC, Angel JB
    Medical Assistance in Death as a Unique Opportunity to Advance HIV Cure Research.
    Clin Infect Dis. 2019 Jan 31. pii: 5304835. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  10. DE FRANCESCO D, Underwood J, Bagkeris E, Boffito M, et al
    Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV-negative controls.
    HIV Med. 2019 Feb 8. doi: 10.1111/hiv.12714.
    PubMed     Text format     Abstract available

  11. AMELE S, Peters L, Sluzhynska M, Yakovlev A, et al
    Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA.
    HIV Med. 2019 Feb 8. doi: 10.1111/hiv.12711.
    PubMed     Text format     Abstract available

  12. BOYD MA, Boffito M, Castagna A, Estrada V, et al
    Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps.
    HIV Med. 2019;20 Suppl 1:3-11.
    PubMed     Text format     Abstract available

  13. JACQUET JM, Donnadieu-Rigole H, Peries M, Makinson A, et al
    Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study.
    HIV Med. 2019 Jan 31. doi: 10.1111/hiv.12709.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  14. HOJILLA JC, Satre DD, Glidden DV, McMahan VM, et al
    Cocaine Use and Pre-Exposure Prophylaxis: Adherence, Care Engagement, and Kidney Function.
    J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001972.
    PubMed     Text format     Abstract available

  15. O'BRIEN DP, Ford N, Djirmay AG, Calmy A, et al
    Female Genital Schistosomiasis and HIV: Research urgently needed to improve understanding of the health impacts of this important co-infection.
    J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001957.
    PubMed     Text format     Abstract available

  16. DARBES LA, Mcgrath NM, Hosegood V, Johnson MO, et al
    Results of a couples-based randomized controlled trial aimed to increase testing for HIV.
    J Acquir Immune Defic Syndr. 2019 Jan 30. doi: 10.1097/QAI.0000000000001948.
    PubMed     Text format     Abstract available

  17. GREWAL R, Allen VG, Bayoumi AM, Gardner SL, et al
    Syphilis co-infection is not associated with an increased risk of virologic failure among HIV-positive men who have sex with men on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2019 Jan 25. doi: 10.1097/QAI.0000000000001962.
    PubMed     Text format     Abstract available


    J Infect Dis

  18. LEUNG J, Peacock A, Colledge S, Grebely J, et al
    A global meta-analysis on HIV, hepatitis C and hepatitis B among people who inject drugs - do gender differences vary by country-level indicators?
    J Infect Dis. 2019 Feb 6. pii: 5307802. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. SORTINO O, Huppler Hullsiek K, Richards E, Rupert A, et al
    The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among People Living with HIV Receiving Antiretroviral Therapy.
    J Infect Dis. 2019 Feb 4. pii: 5306488. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. COHEN MS, Donnell D
    Novel approaches for development of HIV pre-exposure prophylaxis (PrEP) agents.
    J Infect Dis. 2019 Jan 31. pii: 5304967. doi: 10.1093.
    PubMed     Text format    

  21. KARLSSON I, Tingstedt JL, Sahin GO, Hansen M, et al
    Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals.
    J Infect Dis. 2019 Feb 2. pii: 5305980. doi: 10.1093.
    PubMed     Text format     Abstract available

  22. MULLICK C, Murray J
    Correlations between HIV infection and rectal gonorrhea incidence in men who have sex with men: Implications for future HIV pre-exposure prophylaxis trials.
    J Infect Dis. 2019 Jan 31. pii: 5304966. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  23. BANG BR, Li M, Tsai KN, Aoyagi H, et al
    Regulation of HCV infection by Cellular Retinoic Acid Binding Proteins through the modulation of lipid droplet abundance.
    J Virol. 2019 Feb 6. pii: JVI.02302-18. doi: 10.1128/JVI.02302.
    PubMed     Text format     Abstract available

  24. WEI W, Wiggins J, Hu D, Vrbanac V, et al
    Blocking HIV-1 infection by chromosomal integrative expression of human CD4 on the surface of Lactobacillus helveticus R0052.
    J Virol. 2019 Feb 6. pii: JVI.01830-18. doi: 10.1128/JVI.01830.
    PubMed     Text format     Abstract available

  25. UPPAL T, Meyer D, Agrawal A, Verma SC, et al
    The DNase Activity of KSHV SOX Protein Serves an Important Role in Viral Genome Processing During Lytic Replication.
    J Virol. 2019 Feb 6. pii: JVI.01983-18. doi: 10.1128/JVI.01983.
    PubMed     Text format     Abstract available


    JAMA

  26. FAUCI AS, Redfield RR, Sigounas G, Weahkee MD, et al
    Ending the HIV Epidemic: A Plan for the United States.
    JAMA. 2019 Feb 7. pii: 2724455. doi: 10.1001/jama.2019.1343.
    PubMed     Text format    


    Lancet

  27. KROIDL A, Eberle J
    A two-drug regimen for antiretroviral therapy.
    Lancet. 2019;393:106-108.
    PubMed     Text format    

  28. GOSTIN L, Phelan A, Coutinho AG, Eccleston-Turner M, et al
    Ebola in the Democratic Republic of the Congo: time to sound a global alert?
    Lancet. 2019 Feb 1. pii: S0140-6736(19)30243.
    PubMed     Text format    


    Lancet Haematol

  29. NASTOUPIL LJ, Lunning MA, Vose JM, Schreeder MT, et al
    Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial.
    Lancet Haematol. 2019;6:e100-e109.
    PubMed     Text format     Abstract available


    Lancet HIV

  30. KIRBY T
    San Francisco AIDS Foundation.
    Lancet HIV. 2019;6:e79.
    PubMed     Text format    

  31. FINNERTY F, Azad Y, Orkin C
    Hostile health-care environment could increase migrants' risk of HIV and prevent access to vital services.
    Lancet HIV. 2019;6:e76.
    PubMed     Text format    


  32. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration.
    Lancet HIV. 2019;6:e105-e115.
    PubMed     Text format     Abstract available

  33. KERR SJ, Puthanakit T
    Barriers to paediatric switching to second-line ART.
    Lancet HIV. 2019;6:e71-e72.
    PubMed     Text format    

  34. SIERRA-MADERO JG, Belaunzaran-Zamudio PF, Crabtree-Ramirez B, Magis-Rodriguez C, et al
    Mexico's fragmented health system as a barrier to HIV care.
    Lancet HIV. 2019;6:e74-e75.
    PubMed     Text format    


    Lancet Infect Dis

  35. WALKER S, Stoove M, Wilson M, Higgs P, et al
    Understanding HIV and hepatitis C virus risk among incarcerated young men with histories of injecting drug use.
    Lancet Infect Dis. 2019;19:130-131.
    PubMed     Text format    

  36. ABOUD M, Kaplan R, Lombaard J, Zhang F, et al
    Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial.
    Lancet Infect Dis. 2019 Feb 4. pii: S1473-3099(19)30036.
    PubMed     Text format     Abstract available


    Lancet Psychiatry

  37. VIGO DV, Patel V, Becker A, Bloom D, et al
    A partnership for transforming mental health globally.
    Lancet Psychiatry. 2019 Jan 28. pii: S2215-0366(18)30434.
    PubMed     Text format     Abstract available


    Lancet Public Health

  38. SUNG H, Siegel RL, Rosenberg PS, Jemal A, et al
    Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry.
    Lancet Public Health. 2019 Feb 1. pii: S2468-2667(18)30267.
    PubMed     Text format     Abstract available


    N Engl J Med

  39. MARCUS JL, Katz KA, Krakower DS, Calabrese SK, et al
    Risk Compensation and Clinical Decision Making - The Case of HIV Preexposure Prophylaxis.
    N Engl J Med. 2019;380:510-512.
    PubMed     Text format    


    Pediatr Infect Dis J

  40. NESHEIM SR, FitzHarris LF, Gray KM, Lampe MA, et al
    Epidemiology of Perinatal HIV Transmission in the United States in the Era of Its Elimination.
    Pediatr Infect Dis J. 2019 Feb 4. doi: 10.1097/INF.0000000000002290.
    PubMed     Text format     Abstract available

  41. DOW DE, Shayo AM, Cunningham CK, Mmbaga B, et al
    HIV-1 Drug Resistance and Virologic Outcomes Among Tanzanian Youth Living with HIV.
    Pediatr Infect Dis J. 2019 Feb 4. doi: 10.1097/INF.0000000000002288.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  42. WODARZ D, Skinner PJ, Levy DN, Connick E, et al
    Virus and CTL dynamics in the extrafollicular and follicular tissue compartments in SIV-infected macaques.
    PLoS Comput Biol. 2018;14:e1006461.
    PubMed     Text format     Abstract available


    PLoS Med

  43. BHATIA T, Enoch J, Khan M, Mathewson S, et al
    Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?
    PLoS Med. 2019;16:e1002735.
    PubMed     Text format     Abstract available


    PLoS One

  44. MULONGENI P, Hermans S, Caldwell J, Bekker LG, et al
    HIV prevalence and determinants of loss-to-follow-up in adolescents and young adults with tuberculosis in Cape Town.
    PLoS One. 2019;14:e0210937.
    PubMed     Text format     Abstract available

  45. KIWEEWA F, Esber A, Musingye E, Reed D, et al
    HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
    PLoS One. 2019;14:e0211344.
    PubMed     Text format     Abstract available

  46. BVOCHORA T, Satyanarayana S, Takarinda KC, Bara H, et al
    Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: Operational issues.
    PLoS One. 2019;14:e0211326.
    PubMed     Text format     Abstract available

  47. YIRDAW KD, Teklu AM, Mamuye AT, Zewdu S, et al
    Breakthrough tuberculosis disease among people with HIV - Should we be worried? A retrospective longitudinal study.
    PLoS One. 2019;14:e0211688.
    PubMed     Text format     Abstract available

  48. BOBARDT M, Kuo J, Chatterji U, Chanda S, et al
    The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate.
    PLoS One. 2019;14:e0211746.
    PubMed     Text format     Abstract available

  49. DJIMEU EW, Heard AC
    Treatment of HIV among tuberculosis patients: A replication study of timing of antiretroviral therapy for HIV-1-associated tuberculosis.
    PLoS One. 2019;14:e0210327.
    PubMed     Text format     Abstract available

  50. SHENGE JA, Odaibo GN, Olaleye DO
    Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria.
    PLoS One. 2019;14:e0210724.
    PubMed     Text format     Abstract available

  51. VAN OMMEN CE, Albert AYK, Piske M, Money DM, et al
    Exploring the live birth rates of women living with HIV in British Columbia, Canada.
    PLoS One. 2019;14:e0211434.
    PubMed     Text format     Abstract available

  52. ASANTE-POKU A, Asare P, Baddoo NA, Forson A, et al
    TB-diabetes co-morbidity in Ghana: The importance of Mycobacterium africanum infection.
    PLoS One. 2019;14:e0211822.
    PubMed     Text format     Abstract available

  53. DRAIN PK, Hong T, Hajat A, Krows M, et al
    Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa.
    PLoS One. 2019;14:e0210161.
    PubMed     Text format     Abstract available

  54. HUANG YC, Huang YF, Lin MH, Yang JY, et al
    An outbreak of HIV infection among people who inject drugs linked to injection of propofol in Taiwan.
    PLoS One. 2019;14:e0210210.
    PubMed     Text format     Abstract available

  55. MARTINEZ L, Milanic M, Malaina I, Alvarez C, et al
    Weighted lambda superstrings applied to vaccine design.
    PLoS One. 2019;14:e0211714.
    PubMed     Text format     Abstract available

  56. ZUNGU NP, Mabaso ML, Kumalo F, Sigida S, et al
    Prevalence of non-communicable diseases (NCDs) and associated factors among HIV positive educators: Findings from the 2015/6 survey of Health of Educators in Public Schools in South Africa.
    PLoS One. 2019;14:e0209756.
    PubMed     Text format     Abstract available

  57. RASMUSSEN DN, Unger HW, Bjerregaard-Andersen M, da Silva Te D, et al
    Correction: Political instability and supply-side barriers undermine the potential for high participation in HIV testing for the prevention of mother-to-child transmission in Guinea-Bissau: A retrospective cross-sectional study.
    PLoS One. 2019;14:e0212240.
    PubMed     Text format     Abstract available

  58. BULLA I, Spicknall IH, Gromov D, Romero-Severson EO, et al
    Correction: Sensitivity of joint contagiousness and susceptibility-based dynamic optimal control strategies for HIV prevention.
    PLoS One. 2019;14:e0212251.
    PubMed     Text format     Abstract available

  59. BENZEKRI NA, Seydi M, N Doye I, Toure M, et al
    Correction: Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015.
    PLoS One. 2019;14:e0212250.
    PubMed     Text format     Abstract available


    PLoS Pathog

  60. CHONG H, Xue J, Zhu Y, Cong Z, et al
    Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques.
    PLoS Pathog. 2019;15:e1007552.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  61. BIBOLLET-RUCHE F, Russell RM, Liu W, Stewart-Jones GBE, et al
    CD4 receptor diversity in chimpanzees protects against SIV infection.
    Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1821197116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: